Farah Shaukat

Family Medicine

29624 Network Pl
Chicago, IL 60673

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review.

UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review.

Journal: Modern rheumatology case reports

Published: June 14, 2021

Employing a mobile health decision aid to improve decision-making for patients with advanced prostate cancer and their decision partners/proxies: the CHAMPION randomized controlled trial study design.

Employing a mobile health decision aid to improve decision-making for patients with advanced prostate cancer and their decision partners/proxies: the CHAMPION randomized controlled trial study design.

Journal: Trials

Published: May 24, 2021

Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer.

Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer.

Journal: European urology

Published: February 21, 2019

Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations.

Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations.

Journal: European urology

Published: June 29, 2018

Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy.

Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: August 16, 2013

Showing 1-5 of 5

Last Updated: 09/26/2026